G. Sicignano
Papers
1
Total Citations
45
H-Index
1
About
G. Sicignano is a radiation oncologist whose research focuses on advancing precision radiotherapy techniques, particularly for prostate cancer. Their major contributions center on the clinical implementation and validation of moderate hypofractionation combined with volumetric modulated arc therapy and daily image guidance (VMAT-IGRT). Sicignano’s most-cited work, a 2017 mono-institutional report on feasibility and acute toxicity, demonstrated that moderate hypofractionated postprostatectomy VMAT-IGRT is both safe and well-tolerated, with manageable acute toxicity profiles. This study, with 45 citations, has helped establish a foundation for shorter, more convenient treatment regimens without compromising patient outcomes. By rigorously documenting the acute side effects and technical feasibility of this approach, Sicignano has provided critical evidence supporting the broader adoption of hypofractionated protocols in postoperative settings. Their work underscores a commitment to improving the therapeutic ratio—balancing tumor control with quality of life—and has influenced clinical practice guidelines. For students and researchers, Sicignano’s research exemplifies how meticulous clinical investigation can translate advanced radiation technologies into tangible patient benefits, paving the way for further studies on long-term outcomes and comparative effectiveness.
Research Focus
Key Achievements
Top Papers
- 1